The increase in occurrences of chronic diseases in Spain has triggered a growth in biologics market, technological advancements and introduction of new products. The improvement in efficacy of drug delivery, drug safety along with controlling the rate of drug delivery, time, and place of drug release in the body are the major elements affecting the drug delivery technologies. Almost all the companies are manufacturing smart and fast technologies which offer effective treatments for diseases. Majority of manufacturing companies are investing huge funds in the research and development of drug delivery systems that cater to the needs of patients for effective delivery of drugs.
The leading players in global drug delivery technology market are Johnson & Johnson, Inc. (U.S.), F. Hoffman-La Roche (Switzerland), Merck & Co., Inc. (U.S.), Bayer AG (Germany), Pfizer, Inc. (U.S.), Novartis AG (Switzerland), 3M Company (U.S.), Becton, Dickinson and Company (U.S.), GlaxoSmithKline plc, (U.K.), Sanofi (France), and Antares Pharma, Inc. (U.S.). The applications of drug delivery devices are at hospitals, ambulatory surgical centers, home care settings, diagnostic centers, other facilities such as medical data centers, research and clinical laboratories. Drug Delivery devices are used to administer medical drugs via Oral, Injectable, Topical, Ocular, Nasal, Pulmonary, Transmucosal, and Implantable.
The introduction of central venous catheters (CVCs) in Spain has created healthcare reforms with a positive impact and safety. It was observed that CVC’s are the best practices of using and managing invasive devices. CVC’s prevents and control healthcare-associated infections in hospitals, outpatient settings, and home healthcare settings along with associated complications. These key factors led to an increased adoption rate of CVCs in healthcare centres Spain. The increasing awareness about the antimicrobial technology has led to increasing adoption of antimicrobial CVCs. The central venous catheters in Spain are segmented into antimicrobial, non-antimicrobial, and non-tunneled catheter devices. The non-tunneled CVCs are also known as subclavian, percutaneous, and short-term catheters which are used as an alternative to peripherally inserted central catheters (PICC). Healthcares facilitating dialysis procedures for urological and renal disorders witness an increased influx of patients and a large requirement of catheterization. The applications of CVC’s are at multi-specialty hospitals, private hospitals, and hospital groups.
The leading players in the CVC’s in Spain are Teleflex Inc, C. R. Bard Inc, Edwards Lifesciences Corp and B. Braun Melsungen AG. The other vendors in central venous catheters market are Vygon, Cook, Amecath, AngioDynamics, BACTIGUARD, BD, Biosensors International, Boston Scientific, CONMED, Guangdong Baihe Medical Technology, Intra special catheters, isomed, Kimal, lepumedical, Medical Components, PRODIMED, SCW MEDICATH, SILMAG, Smiths Medical, Terumo, TROGE MEDICAL, TUOREN Medical, VOGT MEDICAL, and ZOLL Medical.
According to the study “Spain Drug Delivery Devices Market Outlook to 2023-Central Venous Catheters, Infusion Systems, Needle Free Injections and Metered Dose Inhaler Devices”, large hospitals across the country acquire or merge with medium and small hospitals to enhancing the quality of treatment. Merging improves the capital investment, technology, and infrastructure of the small hospitals. Therefore, more population will prefer quality treatment which in turn demands for infusion pumps and reduces cost. Also, smaller hospitals under the wings of bigger hospitals provide complicated treatments and surgeries that involve infusion of drugs and fluids such as blood and nutrients with the use of infusion pumps. The infusion pumps market in Spain will witness a steady growth over the coming years.
The infusion pumps are manufactured and sold at local and international levels. The global manufacturers focus on improved technologies, high-quality products, and brand image. The increasing demand for infusion pumps and accessories such as injection port, IV cables, syringes, air embolism, infiltration, hematoma, and dose error will have an adverse impact on the infusion pumps market. The applications of global infusion pumps are at the ambulatory surgical centers (ASCs), hospitals, and physician’s offices.
Infusion pumps are used in healthcare facilities to inject fluid drugs, nutrients, and blood in a controlled manner. The adoption of infusion pumps in almost all chronic illnesses and cancer cases is expected rise with modern lifestyle and is sure to support the growth of infusion pumps market over the coming years. Spain infusion systems market is segmented into ambulatory infusion pumps, enteral infusion pumps, implantable infusion pumps, infusion disposable set, syringe pumps and volumetric pumps. The leading players in Spain’s infusion pumps market are Hospira Inc, Becton Dickinson and Co, Baxter International Inc and Medtronic plc. The other vendors in the infusion systems market are Flowonix Medical, InfuSystem, Moog, Medovex, and Zimmer Biomet.
A metered-dose inhaler (MDI) is a device used to deliver a specific amount of medication to the lungs. MDI delivers drug in the form of a short burst of aerosolized medicine through inhalation. MDI is used to treat asthma, chronic obstructive pulmonary disease and other respiratory diseases. With the initiation of macromolecular medications using metered-dose inhaler the scope of aerosol drug delivery is expanding to other non-respiratory illnesses such as diabetes, analgesia, thyroid disorders, and other genetic disease. The leading players in Spain’s metered-dose inhaler market are GlaxoSmithKline Plc, AstraZeneca Plc and Boehringer Ingelheim GmbH. The MDI market in Spain will witness a steady growth over the coming years.
Needle free injection technology (NFIT) includes a wide range of drug delivery systems. Drugs are administered through skin using any of the forces as Lorentz, Shock waves, pressure by gas or electrophoresis nullifying the use of needle. This technology is highly useful in mass immunization programmes. NFIT devices are classified based on their working, type of load, mechanism of drug delivery and site of delivery. The sterility, shelf life and viscosity of drug are the main components for a stable, safe and an effective drug dose through NFIT. The NFIT market in Spain will witness a steady growth over the coming years.
The key factors driving the growth in drug delivery devices market are increased prevalence of chronic diseases, technological advances, increase in individual therapy, increased understanding about drug metabolism among the population, and requirement of controlled drug release. The major challenges faced by Spain’s drug delivery devices market are injuries, infections, high cost and strict regulatory framework. The various drug delivery devices in Spain also include injectable, transdermal, ocular, implantable, oral, nasal, topic and pulmonary drug delivery devices. The major players in Spain’s drug delivery devices are INJEX – Equidyne Systems, Teleflex Inc, B. Braun Melsungen AG, Bioject Medical Technologies Inc, GlaxoSmithKline Plc, Baxter International Inc, Edwards Lifesciences Corp, Antares Pharma Inc, AstraZeneca Plc, Boehringer Ingelheim GmbH, Fresenius Kabi AG, Pfizer Inc, Merck & Co Inc, Becton Dickinson and Co, C. R. Bard Inc, Smiths Medical, Terumo Corp, Teva Pharmaceutical Industries Ltd, Medtronic Plc and Hospira Inc. Overall, the drug delivery devices market in Spain is expected to grow steadily over the coming years.
Key Topics Covered in the Report
Spain Drug Delivery Devices Market Research
Spain Drug Delivery Devices Market Size
Infusion Pumps Market In Spain
Spain Needle Free Injection Technology
Metered-Dose Inhaler (MDI) Market in Spain
Needle Free Injection Technology (NFIT) Market in Spain
Central Venous Catheters Demand in Spain
Global Drug Delivery Technology Market Research
Johnson & Johnson Market Share In Spain
Merck & Co., Inc Market Share In Spain
For more information on the market research report please refer to the below link:
Ankur Gupta, Head Marketing & Communications